APM
SURF

Avidity Partners Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Avidity Partners Management’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,478,699
Closed -$9.7M – 92
2020
Q2 		$9.7M Buy
+1,478,699
New +$5.34M 0.62% 45

Other funds holding SURF

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Avidity Partners Management's SURF Position: Q3 2020 in Review

Avidity Partners Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2020, closing a stake of 1,478,699 shares — an estimated $9.7M sold.

Avidity Partners Management first reported a position in SURF in Q2 2020 and held it in 1 quarter. The position peaked at $9.7M in Q2 2020. 59 funds tracked by Wall St. Rank hold SURF as of Q3 2020.

  • Avidity Partners Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Avidity Partners Management sold 1,478,699 Surface Oncology, Inc. Common Stock shares in Q3 2020, an estimated $9.7M.
  • Avidity Partners Management first reported a position in Surface Oncology, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Avidity Partners Management's Surface Oncology, Inc. Common Stock position peaked at $9.7M in Q2 2020.
  • 59 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2020.

Based on Avidity Partners Management's 13F filing for Q3 2020, filed 16 Nov 2020.